Trials / Completed
CompletedNCT00668655
An Evaluation of the Cosmetic Appearance of Metronidazole Gel (MetroGel®) 1%
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 30 (actual)
- Sponsor
- Galderma R&D · Industry
- Sex
- Female
- Age
- 20 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to determine the cosmetic appearance of metronidazole gel (MetroGel®) 1% with commonly marketed facial foundations.
Detailed description
Evaluate the relationship between treatment with MetroGel® 1% and cosmetic performance with the Subjects' usual cosmetic products. It is expected that the female subjects will be able to use their routine cosmetics after application without affecting the cosmetic product's performance or causing side effects.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Metronidazole Gel | Topical, Once daily for 2 weeks |
Timeline
- Start date
- 2008-02-01
- Primary completion
- 2008-03-01
- Completion
- 2008-03-01
- First posted
- 2008-04-29
- Last updated
- 2022-07-29
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00668655. Inclusion in this directory is not an endorsement.